ICU Medical (ICUI) Stock Forecast, Price Target & Predictions
ICUI Stock Forecast
ICU Medical stock forecast is as follows: an average price target of $172.00 (represents a 1.19% upside from ICUI’s last price of $169.98) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.
ICUI Price Target
The average price target for ICU Medical (ICUI) is $172.00 based on 1-year price targets from 4 Wall Street analysts in the past 3 months, with a price target range of $198.00 to $135.00. This represents a potential 1.19% upside from ICUI's last price of $169.98.
ICUI Analyst Ratings
According to 4 Wall Street analysts, ICU Medical's rating consensus is 'Buy'. The analyst rating breakdown for ICUI stock is 0 'Strong Buy' (0.00%), 2 'Buy' (50.00%), 2 'Hold' (50.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
ICU Medical Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Oct 15, 2024 | Brett Fishbin | KeyBanc | $198.00 | $180.30 | 9.82% | 16.48% |
| Oct 14, 2024 | Michael Toomey | Jefferies | $183.00 | $178.72 | 2.39% | 7.66% |
| Jun 17, 2024 | Jayson Bedford | Raymond James | $135.00 | $117.44 | 14.96% | -20.58% |
| Aug 09, 2022 | - | Raymond James | $190.00 | $188.10 | 1.01% | 11.78% |
| Aug 08, 2022 | - | Raymond James | $208.00 | $179.63 | 15.79% | 22.37% |
| May 10, 2022 | - | Raymond James | $235.00 | $201.17 | 16.82% | 38.25% |
The latest ICU Medical stock forecast, released on Oct 15, 2024 by Brett Fishbin from KeyBanc, set a price target of $198.00, which represents a 9.82% increase from the stock price at the time of the forecast ($180.30), and a 16.48% increase from ICUI last price ($169.98).
ICU Medical Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 2 | 3 |
| Avg Price Target | - | $190.50 | $172.00 |
| Last Closing Price | $169.98 | $169.98 | $169.98 |
| Upside/Downside | -100.00% | 12.07% | 1.19% |
In the current month, the average price target of ICU Medical stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to ICU Medical's last price of $169.98. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 15, 2024 | KeyBanc | Overweight | Overweight | Hold |
| Oct 14, 2024 | Jefferies | - | Hold | Initialise |
| Sep 12, 2024 | Raymond James | Outperform | Outperform | Hold |
| Aug 08, 2024 | Raymond James | Outperform | Outperform | Hold |
| Jun 21, 2024 | Needham | - | Hold | Initialise |
| Aug 08, 2022 | Raymond James | Outperform | Outperform | Hold |
| May 10, 2022 | Raymond James | Outperform | Outperform | Hold |
| Feb 28, 2022 | Raymond James | Outperform | Outperform | Hold |
ICU Medical's last stock rating was published by KeyBanc on Oct 15, 2024. The company gave ICUI a "Overweight" rating, the same as its previous rate.
ICU Medical Financial Forecast
ICU Medical Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $587.86M | - | $549.31M | $568.65M | $578.01M | $597.86M | $561.00M | $543.12M | $340.52M | $336.06M | $321.68M | $318.05M | $320.45M | $318.57M | $303.38M | $328.61M | $315.52M | $307.47M |
| Avg Forecast | $639.10M | $622.80M | $625.60M | $590.30M | $621.35M | $604.35M | $604.85M | $574.55M | $594.97M | $574.60M | $556.64M | $552.25M | $562.98M | $565.75M | $565.20M | $561.13M | $578.77M | $565.00M | $559.93M | $553.17M | $319.90M | $314.30M | $305.87M | $300.90M | $295.33M | $284.70M | $276.70M | $296.30M | $295.70M | $291.17M |
| High Forecast | $649.13M | $632.57M | $635.42M | $599.56M | $631.10M | $613.83M | $614.34M | $580.00M | $608.11M | $576.93M | $565.37M | $560.92M | $566.10M | $574.63M | $574.07M | $569.94M | $587.85M | $565.00M | $559.93M | $553.17M | $319.90M | $314.30M | $305.87M | $300.90M | $295.33M | $284.70M | $276.70M | $296.30M | $295.70M | $291.17M |
| Low Forecast | $628.00M | $611.98M | $614.73M | $580.05M | $610.56M | $593.85M | $594.34M | $569.10M | $580.29M | $572.28M | $546.97M | $542.66M | $558.42M | $555.92M | $555.38M | $551.39M | $568.71M | $565.00M | $559.93M | $553.17M | $319.90M | $314.30M | $305.87M | $300.90M | $295.33M | $284.70M | $276.70M | $296.30M | $295.70M | $291.17M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 4 | 6 | 4 | 4 | 7 | 4 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.04% | - | 0.97% | 1.01% | 1.00% | 1.06% | 1.00% | 0.98% | 1.06% | 1.07% | 1.05% | 1.06% | 1.09% | 1.12% | 1.10% | 1.11% | 1.07% | 1.06% |
ICU Medical's average Quarter revenue forecast for Mar 24 based on 1 analysts is $552.25M, with a low forecast of $542.66M, and a high forecast of $560.92M. ICUI's average Quarter revenue forecast represents a -6.06% decrease compared to the company's last Quarter revenue of $587.86M (Dec 23).
ICU Medical EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 4 | 6 | 4 | 4 | 7 | 4 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $-12.18M | - | $2.76M | $75.18M | $7.41M | $68.79M | $-14.25M | $45.89M | $46.84M | $55.56M | $59.57M | $51.78M | $54.23M | $50.58M | $45.45M | $43.84M | $43.09M | $54.08M |
| Avg Forecast | $89.60M | $87.32M | $87.71M | $82.76M | $87.11M | $84.73M | $84.80M | $80.55M | $83.41M | $80.56M | $78.04M | $12.05M | $78.93M | $79.32M | $79.24M | $10.95M | $45.87M | $63.34M | $62.77M | $11.71M | $35.86M | $35.24M | $34.29M | $47.64M | $33.11M | $31.92M | $31.02M | $39.00M | $33.15M | $32.64M |
| High Forecast | $91.01M | $88.69M | $89.09M | $84.06M | $88.48M | $86.06M | $86.13M | $81.32M | $85.26M | $80.89M | $79.27M | $14.45M | $79.37M | $80.56M | $80.48M | $13.14M | $55.04M | $63.34M | $62.77M | $14.05M | $35.86M | $35.24M | $34.29M | $57.17M | $33.11M | $31.92M | $31.02M | $46.80M | $33.15M | $32.64M |
| Low Forecast | $88.05M | $85.80M | $86.19M | $81.32M | $85.60M | $83.26M | $83.33M | $79.79M | $81.36M | $80.23M | $76.69M | $9.64M | $78.29M | $77.94M | $77.86M | $8.76M | $36.69M | $63.34M | $62.77M | $9.37M | $35.86M | $35.24M | $34.29M | $38.11M | $33.11M | $31.92M | $31.02M | $31.20M | $33.15M | $32.64M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -0.15% | - | 0.03% | 6.87% | 0.16% | 1.09% | -0.23% | 3.92% | 1.31% | 1.58% | 1.74% | 1.09% | 1.64% | 1.58% | 1.47% | 1.12% | 1.30% | 1.66% |
1 analysts predict ICUI's average Quarter EBITDA for Sep 23 to be $79.32M, with a high of $80.56M and a low of $77.94M. This is 2773.86% upper than ICU Medical's previous annual EBITDA (Jun 23) of $2.76M.
ICU Medical Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 4 | 6 | 4 | 4 | 7 | 4 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $-17.15M | - | $-9.93M | $-9.81M | $-15.54M | $-13.21M | $-7.47M | $-38.07M | $19.93M | $31.08M | $28.40M | $23.73M | $26.14M | $24.99M | $18.91M | $16.83M | $20.64M | $26.56M |
| Avg Forecast | $57.61M | $53.49M | $51.40M | $41.27M | $48.55M | $43.83M | $42.52M | $34.38M | $36.29M | $30.54M | $24.39M | $-38.27M | $29.14M | $33.85M | $39.10M | $-34.79M | $19.51M | $35.70M | $40.49M | $-37.21M | $40.09M | $43.83M | $40.00M | $21.83M | $36.83M | $31.87M | $30.25M | $14.98M | $39.76M | $39.44M |
| High Forecast | $58.78M | $54.58M | $52.45M | $42.11M | $49.54M | $44.72M | $43.39M | $38.71M | $37.81M | $30.61M | $24.89M | $-30.62M | $29.88M | $33.88M | $39.90M | $-27.83M | $23.41M | $35.70M | $40.49M | $-29.77M | $40.09M | $43.83M | $40.00M | $26.20M | $36.83M | $31.87M | $30.25M | $17.97M | $39.76M | $39.44M |
| Low Forecast | $56.30M | $52.28M | $50.24M | $40.34M | $47.45M | $42.84M | $41.56M | $30.05M | $33.75M | $30.47M | $23.84M | $-45.93M | $27.91M | $33.81M | $38.22M | $-41.75M | $15.61M | $35.70M | $40.49M | $-44.66M | $40.09M | $43.83M | $40.00M | $17.47M | $36.83M | $31.87M | $30.25M | $11.98M | $39.76M | $39.44M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -0.59% | - | -0.25% | 0.28% | -0.80% | -0.37% | -0.18% | 1.02% | 0.50% | 0.71% | 0.71% | 1.09% | 0.71% | 0.78% | 0.63% | 1.12% | 0.52% | 0.67% |
ICU Medical's average Quarter net income forecast for Mar 22 is $-37.21M, with a range of $-44.66M to $-29.77M. ICUI's average Quarter net income forecast represents a -286.76% decrease compared to the company's last Quarter net income of $19.93M (Dec 21).
ICU Medical SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 4 | 6 | 4 | 4 | 7 | 4 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $154.62M | - | $150.90M | $152.57M | $142.93M | $153.45M | $158.75M | $153.21M | $81.46M | $74.81M | $73.92M | $72.39M | $73.55M | $70.85M | $67.24M | $72.31M | $70.65M | $65.88M |
| Avg Forecast | $154.33M | $150.39M | $151.07M | $142.55M | $150.04M | $145.94M | $146.06M | $138.74M | $143.67M | $138.76M | $134.42M | $154.04M | $135.95M | $136.62M | $136.48M | $140.03M | $79.77M | $135.34M | $134.13M | $149.77M | $76.63M | $75.29M | $73.27M | $66.60M | $70.75M | $68.20M | $66.28M | $64.32M | $70.83M | $69.75M |
| High Forecast | $156.75M | $152.75M | $153.44M | $144.78M | $152.40M | $148.23M | $148.35M | $140.06M | $146.85M | $139.32M | $136.53M | $184.84M | $136.70M | $138.76M | $138.63M | $168.04M | $95.72M | $135.34M | $134.13M | $179.72M | $76.63M | $75.29M | $73.27M | $79.92M | $70.75M | $68.20M | $66.28M | $77.18M | $70.83M | $69.75M |
| Low Forecast | $151.65M | $147.78M | $148.45M | $140.07M | $147.44M | $143.40M | $143.52M | $137.43M | $140.13M | $138.19M | $132.08M | $123.23M | $134.85M | $134.24M | $134.11M | $112.03M | $63.81M | $135.34M | $134.13M | $119.82M | $76.63M | $75.29M | $73.27M | $53.28M | $70.75M | $68.20M | $66.28M | $51.46M | $70.83M | $69.75M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.14% | - | 1.11% | 1.09% | 1.79% | 1.13% | 1.18% | 1.02% | 1.06% | 0.99% | 1.01% | 1.09% | 1.04% | 1.04% | 1.01% | 1.12% | 1.00% | 0.94% |
ICU Medical's average Quarter SG&A projection for Mar 24 is $154.04M, based on 1 Wall Street analysts, with a range of $123.23M to $184.84M. The forecast indicates a -0.37% fall compared to ICUI last annual SG&A of $154.62M (Dec 23).
ICU Medical EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 4 | 2 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 4 | 6 | 4 | 4 | 7 | 4 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $-0.71 | - | $-0.41 | $-0.41 | $-0.65 | $-0.55 | $-0.31 | $-1.61 | $0.94 | $1.47 | $1.34 | $1.12 | $1.24 | $1.19 | $0.91 | $0.81 | $1.00 | $1.29 |
| Avg Forecast | $2.36 | $2.19 | $2.10 | $1.69 | $1.99 | $1.79 | $1.74 | $1.41 | $1.49 | $1.25 | $1.00 | $0.82 | $1.19 | $1.39 | $1.60 | $1.43 | $1.56 | $1.46 | $1.66 | $1.80 | $1.64 | $1.80 | $1.64 | $1.50 | $1.51 | $1.31 | $1.24 | $1.63 | $1.63 | $1.62 |
| High Forecast | $2.41 | $2.23 | $2.15 | $1.72 | $2.03 | $1.83 | $1.78 | $1.58 | $1.55 | $1.25 | $1.02 | $0.84 | $1.22 | $1.39 | $1.63 | $1.43 | $1.59 | $1.46 | $1.66 | $1.80 | $1.64 | $1.80 | $1.64 | $1.50 | $1.51 | $1.31 | $1.24 | $1.63 | $1.63 | $1.62 |
| Low Forecast | $2.30 | $2.14 | $2.06 | $1.65 | $1.94 | $1.75 | $1.70 | $1.23 | $1.38 | $1.25 | $0.98 | $0.80 | $1.14 | $1.38 | $1.56 | $1.43 | $1.52 | $1.46 | $1.66 | $1.80 | $1.64 | $1.80 | $1.64 | $1.50 | $1.51 | $1.31 | $1.24 | $1.63 | $1.63 | $1.62 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -0.60% | - | -0.26% | -0.29% | -0.42% | -0.38% | -0.19% | -0.89% | 0.57% | 0.82% | 0.82% | 0.75% | 0.82% | 0.91% | 0.73% | 0.50% | 0.61% | 0.80% |
According to 1 Wall Street analysts, ICU Medical's projected average Quarter EPS for Mar 22 is $1.80, with a low estimate of $1.80 and a high estimate of $1.80. This represents a 91.49% increase compared to ICUI previous annual EPS of $0.94 (Dec 21).
ICU Medical Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| COO | Cooper Companies | $99.48 | $298.00 | 199.56% | Buy |
| AKYA | Akoya Biosciences | $2.09 | $5.30 | 153.59% | Buy |
| ANGO | AngioDynamics | $6.88 | $15.00 | 118.02% | Buy |
| XRAY | DENTSPLY SIRONA | $18.46 | $40.00 | 116.68% | Hold |
| ATRC | AtriCure | $34.72 | $49.57 | 42.77% | Buy |
| HAE | Haemonetics | $88.17 | $108.25 | 22.77% | Buy |
| NVST | Envista | $20.61 | $23.11 | 12.13% | Hold |
| HOLX | Hologic | $78.79 | $80.21 | 1.80% | Buy |
| ICUI | ICU Medical | $169.98 | $172.00 | 1.19% | Buy |
| MMSI | Merit Medical Systems | $103.94 | $100.78 | -3.04% | Buy |
| ATR | AptarGroup | $166.69 | $138.00 | -17.21% | Buy |